ADEERA LEVIN

ADEERA LEVIN specializes in high-level scientific and technical consulting services, with a focused expertise in leading complex biomedical research initiatives as an independent expert advisor. Their core capability centers on chairing strategic steering committees for national health research consortia, providing scientific governance, interdisciplinary coordination, and evidence-based decision-making frameworks to advance therapeutic development pipelines. The contractor brings deep domain knowledge in clinical trial design, translational medicine, and consortium management, particularly within the context of rare disease and chronic condition research. Their unique differentiator lies in combining clinical authority with systems-level leadership, enabling alignment among academic, industry, and government stakeholders to accelerate scientific outcomes. Technical expertise includes regulatory pathway navigation, data governance for multi-site trials, and the integration of patient-centered outcomes into research priorities. ADEERA LEVIN has delivered consulting services to the Department of Health and Human Services, specifically supporting the National Institute of Diabetes and Digestive and Kidney Diseases in the oversight of a national cure-focused research consortium. The engagement reflects a pattern of trusted advisory roles in mission-critical, science-driven initiatives requiring expert leadership and neutral facilitation of multi-institutional collaboration. The primary NAICS category, 541690, reflects a niche positioning in non-routine, high-expertise scientific consulting—distinct from general management or administrative services. This places the contractor at the intersection of biomedical research leadership and federal science policy, serving specialized needs within the public health research ecosystem. As a Woman-Owned Business operating from Vancouver, BC, ADEERA LEVIN is structured as a sole proprietorship (2J), reflecting a lean, expertise-driven operational model. The entity leverages its certification to enhance accessibility to federal contracting opportunities focused on diversity and specialized professional services, positioning itself as a trusted independent authority in U.S. health research governance.